NEWS

  • April 28, 2020

    AtaCor Medical Secures $25M Financing to Continue Extracardiac Pacing Development

    April 28, 2020 SAN CLEMENTE, Calif.--(BUSINESS WIRE)--AtaCor Medical, Inc. announced today that is has completed a $25M Series B financing. The financing syndicate, led by a corporate partner, in...

    Read More
  • March 23, 2020

    CroíValve announces successful first human use of its Duo Tricuspid Coaptation Valve technology

    Dublin, Ireland, 23 March 2020 - CroíValve announced today the successful first human use of its Duo Tricuspid Coaptation Valve technology for tricuspid repair. The procedure was performed by an expe...

    Read More
  • February 24, 2020

    Anne Prener, M.D., Ph.D. Appointed to Renovacor Board of Directors and Scientific Advisory Board

    Philadelphia, PA, February 24, 2020 – Renovacor, Inc, a preclinical-stage biopharmaceutical company focused on developing transformative gene therapy-based treatments for cardiovascular disease, tod...

    Read More
  • February 6, 2020

    Aria CV Receives FDA Breakthrough Designation for Its Medical Device for Treating Pulmonary Arterial Hypertension

    February 06, 2020 07:00 AM Eastern Standard Time SAINT PAUL, Minn.--(BUSINESS WIRE)--Aria CV, Inc., a developer of medical devices treating Pulmonary Arterial Hypertension (PAH), today announced tha...

    Read More
  • November 5, 2019

    Aeromics and Simcere Announce Collaboration and License Agreement for AER-271 in Greater China

    November 5, 2019 3:30pm Eastern Daylight Time NEW HAVEN, Conn. and NANJING, China, (PRNewswire.com) - Simcere Pharmaceutical Group and Aeromics, Inc. today announce collaboration and exclusive lice...

    Read More
  • November 4, 2019

    Kantum Pharma Founder to Present Preclinical Data Demonstrating Beneficial Effects of P2Y14 Antagonist in Acute Kidney Injury at the American Society of Nephrology Annual Meeting

    November 4, 2019 3:30pm Eastern Daylight Time CAMBRIDGE, MA (Newswire.com) - ​Kantum Pharma Inc., a biopharmaceutical company focused on developing therapies for the prevention and treatment of d...

    Read More
  • September 12, 2019

    CroíValve Secures €4M in Additional Funding to Initiate Clinical Trials

    September 12, 2019 07:00 AM Eastern Daylight Time DUBLIN (BUSINESS WIRE)– €4 million in additional financing has been secured by CroíValve, a high potential start-up (HPSU) supported by Enterp...

    Read More
  • August 14, 2019

    Renovacor Closes $11 Million Series A Financing to Advance First Gene Therapy for a Rare Cardiovascular Disease

    August 14, 2019 07:00 AM Eastern Daylight Time PHILADELPHIA--(BUSINESS WIRE)--Renovacor, Inc, a preclinical-stage biopharmaceutical company focused on developing transformative gene therapy-...

    Read More
  • February 11, 2019

    FineHeart makes Fierce Medtech’s 2018 List

    February 11, 2019. FineHeart makes Fierce Medtech’s 2018 list of 15 exciting/innovative companies to watch. FierceMedTech’s Fierce 15 class of 2018 is aimed at advancement—whether it’s simpl...

    Read More
  • February 6, 2019

    Broadview Ventures 2018 Annual Report

    Broadview Ventures 2018 Annual Report...

    Read More